Pages that link to "Q43073033"
Jump to navigation
Jump to search
The following pages link to Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial (Q43073033):
Displaying 50 items.
- Gabapentin for chronic neuropathic pain and fibromyalgia in adults (Q24194998) (← links)
- Gabapentin for chronic neuropathic pain and fibromyalgia in adults (Q24235709) (← links)
- Gabapentin for acute and chronic pain (Q24235992) (← links)
- Anticonvulsant drugs for acute and chronic pain (Q24241100) (← links)
- Gabapentin for acute and chronic pain (Q24246411) (← links)
- Anticonvulsant drugs for acute and chronic pain (Q24246524) (← links)
- (Q24632313) (← links)
- Effects of treatments for symptoms of painful diabetic neuropathy: systematic review (Q24676584) (← links)
- An evidence-based algorithm for the treatment of neuropathic pain (Q24680820) (← links)
- Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigation (Q27498844) (← links)
- Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin (Q28485343) (← links)
- The effectiveness of anticonvulsants in psychiatric disorders (Q28744504) (← links)
- Maximizing life's potentials in AIDS: a psychopharmacologic update. (Q30327314) (← links)
- Anticonvulsant drugs for acute and chronic pain. (Q30887356) (← links)
- Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies (Q30988464) (← links)
- Treatment of diabetic sensory polyneuropathy (Q33393882) (← links)
- Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation (Q33870062) (← links)
- Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy (Q34112912) (← links)
- Anticonvulsants in neuropathic pain: rationale and clinical evidence (Q34117743) (← links)
- The interface of psychiatric disorders and diabetes mellitus (Q34251441) (← links)
- Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy (Q34251691) (← links)
- Diabetic neuropathy: clinical manifestations and current treatments (Q34275990) (← links)
- Gabapentin for chronic neuropathic pain in adults. (Q34557703) (← links)
- An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy (Q34590272) (← links)
- Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials (Q34602085) (← links)
- Management strategies for the treatment of neuropathic pain in the elderly (Q35031748) (← links)
- Emerging trends in the pharmacotherapy of chronic pain (Q35094653) (← links)
- Management of neuropathy and foot problems in diabetic patients (Q35151329) (← links)
- Gabapentin: a viewpoint by Ian Gilron (Q35554283) (← links)
- New treatments for diabetic neuropathy: Symptomatic treatments (Q35581287) (← links)
- Volume and market share of anti-epileptic drugs in The Netherlands: impact of new drugs (Q36184726) (← links)
- A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin (Q36203460) (← links)
- Practical management of patients with painful diabetic neuropathy (Q36229369) (← links)
- Gabapentin or amitriptyline for painful diabetic neuropathy? (Q36282822) (← links)
- Newer agents for the treatment of painful diabetic peripheral neuropathy (Q36326362) (← links)
- The pharmacotherapy of chronic pain: a review (Q36411163) (← links)
- Clinical Trial Assessing the Efficacy of Gabapentin Plus B Complex (B1/B12) versus Pregabalin for Treating Painful Diabetic Neuropathy (Q36538217) (← links)
- New perspectives on the management of diabetic peripheral neuropathic pain (Q36632037) (← links)
- Pharmacotherapy for neuropathic pain (Q36739954) (← links)
- Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review (Q36803417) (← links)
- Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review (Q36917017) (← links)
- Review of peripheral neuropathy in plasma cell disorders (Q37103845) (← links)
- Does the pharmaceutical industry influence guidelines?: two examples from Germany (Q37199193) (← links)
- Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides (Q37360619) (← links)
- Pregabalin in the treatment of chronic pain: an overview (Q37401263) (← links)
- Distal Symmetric Polyneuropathy: A Review. (Q37444601) (← links)
- Pain associated with diabetic peripheral neuropathy: a review of available treatments (Q37596278) (← links)
- Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature (Q37907386) (← links)
- Management of painful diabetic neuropathy: guideline guidance or jungle? (Q38012664) (← links)
- Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy (Q38093664) (← links)